Follow the QSAM Biosciences, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 14 February 2024 (C). Among the most active insiders: Nelson Christopher M.. All data is accessible without an account.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate QSAM Biosciences, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,885 of 29,063 companies
29.1
score / 100
Value
23
Quality
36
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn45%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
QSAM Biosciences, Inc. es una empresa de biotecnología enfocada en el desarrollo de tratamientos innovadores para el cáncer. Se especializa en la investigación y comercialización de soluciones terapéuticas dirigidas.